THEMIS MEDICARE
Back to Income Statement
|
THEMIS MEDICARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹406 Cr | ₹382 Cr | ₹354 Cr | ₹395 Cr | ₹231 Cr |
What is the latest Revenue of THEMIS MEDICARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹406 Cr |
| Mar2024 | ₹382 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹395 Cr |
| Mar2021 | ₹231 Cr |
How is Revenue of THEMIS MEDICARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹406 Cr | 6.22 | |
| Mar2024 | ₹382 Cr | 7.74 | |
| Mar2023 | ₹354 Cr | -10.21 | |
| Mar2022 | ₹395 Cr | 71.07 | |
| Mar2021 | ₹231 Cr | - | |
Compare Revenue of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹749.3 Cr | 0.1% | -3.4% | -49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | 0.1% |
-3.4% |
-49.4% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses